Physagulin G

Metabolite details

Identifier

LBNOIKRBLYMNFW-UHFFFAOYSA-N

InChI Key

LBNOIKRBLYMNFW-UHFFFAOYSA-N

IUPAC name

[2,16,17-trihydroxy-7,11-dimethyl-6-[1-[5-methyl-6-oxo-4-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-2,3-dihydropyran-2-yl]ethyl]-12-oxo-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadec-13-en-3-yl] acetate

Preferred name

Physagulin G

INN name

—

Synonym

—

ChEBI

CHEBI:185275

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Transcriptome and Metabolome Analyses Reveal Differences in Terpenoid and Flavonoid Biosynthesis in Cryptomeria fortunei Needles Across Different Seasons
• Comparative Metabolomic Profiling of Compatible and Incompatible Interactions Between Potato and Phytophthora infestans
• Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G1_PBS_vs_G2_DSS
• Summer_vs_Winter
• Ziyun_No.1_0h_vs_Ziyun_No.1_96h
• MC-producing_Exponential_vs_MC-free_Exponential